Dimension Capital announces new $800M fund
The science-tech focused fund accelerates deep tech investments.
1Rapid Growth
Despite being founded in 2022, Dimension Capital has successfully raised large funds back-to-back. The new $800M fund is 60% larger than its $500M fund 18 months ago. This demonstrates rapid market acceptance of their science-tech intersection investment thesis.
2Founder Profile
Founded by former Lux Capital and Obvious Ventures partners, Dimension focuses on deep tech companies bridging biotech and software. The founders anticipated rapid growth in this space and have validated their thesis through strategic investments.
3Notable Investments
In 2024, the firm co-led a $30M seed round in Chai Discovery. The open-source AI drug discovery startup announced last week it raised $400M at a $3.8B valuation, showcasing Dimension's early-stage investment acumen.
4Anti-Aging Bet
Dimension backed New Limit in its Series A in January 2025. Co-founded by Coinbase's CEO, the anti-aging startup just closed a Series C at $3.1B valuation, proving the firm's ability to identify transformative opportunities.
5Diverse Portfolio
The firm's portfolio includes Modal Labs and Anthropic. This spring, Anthropic acquired Dimension's portfolio company Coefficient Bio for $400M, strengthening the firm's strategic position in AI-biotech convergence.
6Industry Impact
Dimension's success validates growing investor interest in deep tech. Companies at the science-compute intersection are attracting attention for their high-return potential. This trend signals more funds will flow into this space, reshaping venture capital priorities.
Original article: TechCrunch — Dimension Capital 800 milyon dolarlık yeni fonunu duyurdu